theory clinical_31_8
imports Main

begin

typedecl entity
typedecl event

consts
  βCatenin :: "entity ⇒ bool"
  Expression :: "entity ⇒ bool"
  Genes :: "entity ⇒ bool"
  CyclinD1 :: "entity ⇒ bool"
  Activate :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  NecessaryFor :: "entity ⇒ entity ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Mutations :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  Activity :: "entity ⇒ bool"
  Enhance :: "event ⇒ bool"
  LeadTo :: "event ⇒ event ⇒ bool"
  Promote :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  DueTo :: "entity ⇒ entity ⇒ bool"
  ResultIn :: "event ⇒ bool"
  Cells :: "entity ⇒ bool"
  Ensure :: "event ⇒ bool"
  Occur :: "event ⇒ bool"

(* Explanation 1: β-catenin activates the expression of many genes, including cyclin D1, which is necessary for cell proliferation. *)
axiomatization where
  explanation_1: "∃x y z e. βCatenin x ∧ Expression y ∧ Genes z ∧ CyclinD1 z ∧ Activate e ∧ Agent e x ∧ Patient e y ∧ NecessaryFor y z ∧ Proliferation z"

(* Explanation 2: Activating mutations of CTNNB1 enhance the activity of β-catenin, leading to increased expression of genes like cyclin D1, which directly promotes cell proliferation. *)
axiomatization where
  explanation_2: "∃x y z w e1 e2. Mutations x ∧ CTNNB1 y ∧ βCatenin z ∧ Activity z ∧ Enhance e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Expression w ∧ Genes w ∧ CyclinD1 w ∧ LeadTo e1 e2 ∧ Promote e2 ∧ Agent e2 w ∧ Patient e2 z ∧ Proliferation z"

(* Explanation 3: Enhanced activity of β-catenin, due to activating mutations of CTNNB1, directly promotes cell proliferation via β-catenin. *)
axiomatization where
  explanation_3: "∃x y z e. Activity x ∧ βCatenin x ∧ Mutations y ∧ CTNNB1 y ∧ Proliferation z ∧ βCatenin z ∧ Promote e ∧ Agent e x ∧ Patient e z ∧ Via e z ∧ DueTo x y"

(* Explanation 4: Activating mutations of CTNNB1 result in enhanced activity of β-catenin, which directly promotes the proliferation of cells via β-catenin, ensuring that cell proliferation occurs. *)
axiomatization where
  explanation_4: "∃x y z w e1 e2 e3. Mutations x ∧ CTNNB1 x ∧ Activity y ∧ βCatenin y ∧ Cells z ∧ Proliferation z ∧ βCatenin w ∧ ResultIn e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Promote e2 ∧ Agent e2 y ∧ Patient e2 z ∧ Via e2 w ∧ Ensure e3 ∧ Occur e3 ∧ Agent e3 z"

theorem hypothesis:
  assumes asm: "Mutations x ∧ CTNNB1 y ∧ Cells z"
  (* Hypothesis: Activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
  shows "∃x y z e. Mutations x ∧ CTNNB1 y ∧ Cells z ∧ Proliferation z ∧ βCatenin y ∧ Promote e ∧ Agent e x ∧ Patient e z ∧ Via e y"
proof -
  (* From the premise, we have known information about mutations, CTNNB1, and cells. *)
  from asm have "Mutations x ∧ CTNNB1 y ∧ Cells z" by blast
  
  (* Explanation 4 states that activating mutations of CTNNB1 result in enhanced activity of β-catenin, which directly promotes the proliferation of cells via β-catenin. *)
  (* This explanation directly supports the hypothesis. *)
  (* We can use the logical relation Implies(C, E) from Explanation 2, which states that activating mutations of CTNNB1 enhance the activity of β-catenin, leading to cell proliferation. *)
  have "Proliferation z" sledgehammer
  
  (* Explanation 3 states that enhanced activity of β-catenin, due to activating mutations of CTNNB1, directly promotes cell proliferation via β-catenin. *)
  (* This explanation provides the necessary link to show that the promotion occurs via β-catenin. *)
  have "βCatenin y ∧ Promote e ∧ Agent e x ∧ Patient e z ∧ Via e y" <ATP>
  
  (* Combining the above, we can conclude the hypothesis. *)
  then show ?thesis <ATP>
qed

end
